Citation Impact
Citing Papers
Nuclear Export of MicroRNA Precursors
2003 StandoutScience
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Arsenic-induced changes in the gene expression of lung epithelial L2 cells: implications in carcinogenesis
2008
Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context
2006 StandoutNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Factor Linking Fibrinolysis and Age‐Related Subclinical and Clinical Conditions
2010
The Role of Plasminogen-Plasmin System in Cancer
2009
Emerging principles in protease-based drug discovery
2010
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
2003 Standout
Phage display as a tool for the directed evolution of enzymes
2003
Advances in metal-induced oxidative stress and human disease
2011 Standout
Small‐Molecule Affinity Ligands for Protein Purification: Combined Computational Enrichment and Automated In‐line Screening of an Optically Encoded Library
2010 StandoutNobel
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
2009
Additivity in Effects of Vitronectin and Monoclonal Antibodies against α-Helix F of Plasminogen Activator Inhibitor-1 on Its Reactions with Target Proteinases
2004
Encoded libraries of chemically modified peptides
2015 StandoutNobel
Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide
2015 StandoutNobel
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Survey of the year 2004 commercial optical biosensor literature
2005
Targeting of cancer energy metabolism
2009
The road to fully programmable protein catalysis
2022 StandoutNatureNobel
Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)
2009
MicroRNA biogenesis: coordinated cropping and dicing
2005 Standout
Conserved residue clustering and protein structure prediction
2003 StandoutNobel
Development of a Phage Display Panning Strategy Utilizing Crude Antigens: Isolation of MERS-CoV Nucleoprotein human antibodies
2019
Selection of large diversities of antiidiotypic antibody fragments by phage display
2002 StandoutNobel
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
The selection of intracellular antibodies
1999
Pleiotropic functions of plasminogen activator inhibitor-1
2004
Extracellular matrix structure
2015 Standout
A molecular signature of metastasis in primary solid tumors
2002 Standout
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Unraveling hot spots in binding interfaces: progress and challenges
2002
Antibody phage display technology and its applications
1998
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer
2002
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Lessons learnt from structural studies of the oestrogen receptor
2006
Survey of the year 2003 commercial optical biosensor literature
2004
Exportin-5-mediated nuclear export of eukaryotic elongation factor 1A and tRNA
2002
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Functional Diversity of AAA+ Protease Complexes in Bacillus subtilis
2017 StandoutNobel
Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases
2012 StandoutNobel
Experimental and Computational Analyses of the Energetic Basis for Dual Recognition of Immunity Proteins by Colicin Endonucleases
2008 StandoutNobel
Biogenesis of small RNAs in animals
2009 Standout
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
2004 StandoutNobel
Relationships between sperm DNA fragmentation, sperm apoptotic markers and serum levels of CB-153 and p,p′-DDE in European and Inuit populations
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
Prediction of the structure of symmetrical protein assemblies
2007 StandoutNobel
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target
2012 StandoutNobel
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1
2016 StandoutNobel
Diabetes and Cancer
2010 Standout
Role of Hypoxia-Inducible Factors in Breast Cancer Metastasis
2013 StandoutNobel
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia
2005
Drug Discovery: A Historical Perspective
2000 StandoutScience
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures
2017 StandoutNobel
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1α and Mediates Its Destabilization in a VHL-Independent Manner
2007
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
2004
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
A simple physical model for binding energy hot spots in protein–protein complexes
2002 StandoutNobel
Efficient synthesis of 2,5-diketopiperazines using microwave assisted heating
2006
Works of Troels Wind being referenced
Construction of a plasminogen activator inhibitor‐1 variant without measurable affinity to vitronectin but otherwise normal
2003
The Molecular Basis for Anti-Proteolytic and Non-Proteolytic Functions of Plasminogen Activator Inhibitor Type-1: Roles of the Reactive Centre Loop, the Shutter Region, the Flexible Joint Region and the Small Serpin Fragment
2002
Display of Ras on filamentous phage through cysteine replacement
1999
A Urokinase-type Plasminogen Activator-inhibiting Cyclic Peptide with an Unusual P2 Residue and an Extended Protease Binding Surface Demonstrates New Modalities for Enzyme Inhibition
2005
Identification of phage antibodies toward the Werner protein by selection on Western blots
2000
A model phage display subtraction method with potential for analysis of differential gene expression
1996
Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1
2007
Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases
2003
Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type‐1
2001
The vitronectin binding area of plasminogen activator inhibitor‐1, mapped by mutagenesis and protection against an inactivating organochemical ligand
2002
Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis
2004
A novel pesticide‐induced conformational state of the oestrogen receptor ligand‐binding domain, detected by conformation‐specific peptide binding
2004
Generation and epitope mapping of high‐affinity scFv to eukaryotic elongation factor 1A by dual application of phage display
2001
A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue
2008
Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13
2003
Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1
2003
Inhibition of plasminogen activator inhibitor-1 binding to endocytosis receptors of the low-density-lipoprotein receptor family by a peptide isolated from a phage display library
2006